Showing results (2431-2440 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|March 4, 2015
Neoadjuvant dual HER2-targeted therapy with lapatinib and trastuzumab improves pathologic complete response in patients with early stage HER2-positive breast cancer: a meta-analysis of randomized prospective clinical trialsMellissa Hicks, Erin R Macrae, Mahmoud Abdel-Rasoul, et al.
The Oncologist|July 29, 2020
AR-V7 as a Biomarker for Resistance to Treatment with Abiraterone/Enzalutamide in Three Latin American Countries: A Hypothetical Cost-Saving AnalysisRafael Adrián Pacheco-Orozco, Lorena Montealegre-Páez, Federico Cayol, et al.
The Oncologist|July 28, 2020
Effect of a Structured Teaching Module Including Intensive Prophylactic Measures on Reducing the Incidence of Capecitabine-Induced Hand-Foot Syndrome: Results of a Prospective Randomized Phase III StudyVikas Ostwal, Akhil Kapoor, Sarika Mandavkar, et al.
The Oncologist|August 4, 2020
The Hospitalist Model and Oncology: Oncologist Opinions About Inpatient Cancer Care DeliveryKathleen R Atlas, Barbara C Egan, Caroline J Novak, et al.
The Oncologist|August 4, 2020
Allocating Scarce Health Care Resources During Pandemics: Making the Case for Patients with Advanced and Metastatic CancerAmelia A Langston, Tammie E Quest, Eli Rowe Abernethy, et al.
The Oncologist|July 16, 2020
Phase Ib/II Study of Biweekly TAS-102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS Study)Hironaga Satake, Takeshi Kato, Koji Oba, et al.
The Oncologist|July 12, 2020
Successful Treatment of Patients with Refractory High-Grade Serous Ovarian Cancer with GOPC-ROS1 Fusion Using Crizotinib: A Case ReportDapeng Dong, Ge Shen, Yong Da, et al.
The Oncologist|July 12, 2020
GEICAM Guidelines for the Management of Patients with Breast Cancer During the COVID-19 Pandemic in SpainMiguel Martin, Angel Guerrero-Zotano, Ángel Montero, et al.
The Oncologist|July 15, 2020
Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor ThrombusXiao-Hui Wang, Bing Liao, Wen-Jie Hu, et al.
The Oncologist|July 13, 2020
Erlotinib for Non-Small Cell Lung Cancer with Leptomeningeal Metastases: A Phase II Study (LOGIK1101)Kaname Nosaki, Takeharu Yamanaka, Akinobu Hamada, et al.
Pageof 571